Effects of cigarette smoking and human T-cell leukaemia virus type 1 infection on anti-citrullinated peptide antibody production in Japanese community-dwelling adults: the Nagasaki Islands Study

Scand J Rheumatol. 2021 Jul;50(4):295-298. doi: 10.1080/03009742.2020.1810310. Epub 2020 Sep 22.

Abstract

Objectives: We investigated whether the positivity of anti-citrullinated peptide antibody (ACPA) is associated with cigarette-smoking status and human T-cell leukaemia virus type 1 (HTLV-1) infection in a general population in Nagasaki, Japan, which is an ageing and HTLV-1-endemic area.Method: Baseline data from community-dwelling people in the Nagasaki Islands Study (NaIS) were included in this cross-sectional analysis. ACPA and HTLV-1 were measured in 3887 subjects without a history of treatment for rheumatoid arthritis. A logistic regression analysis was performed to assess the relationship between ACPA positivity and candidates of correlation with ACPA, i.e. the cigarette-smoking status quantified by Brinkman's index (BI) and HTLV-1 positivity.Results: Fifty-one subjects (1.3%) showed ACPA positivity, and 650 subjects (16.6%) were HTLV-1 carriers. In an age- and gender-adjusted logistic regression analysis, the BI [odds ratio (OR) 1.09, 95% confidence interval (CI)1.02-1.14, p = 0.0031] and a BI value > 500 (OR 3.92, 95% CI 1.72-9.22, p = 0.0014) were each significantly associated with ACPA positivity. HTLV-1 positivity did not show any association with ACPA positivity.Conclusion: A significant effect of cigarette-smoking status on ACPA production was revealed, whereas HTLV-1 positivity was not associated with ACPA production in this general population.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Citrullinated Protein Antibodies / blood*
  • Cigarette Smoking / blood
  • Cigarette Smoking / immunology*
  • Cross-Sectional Studies
  • Female
  • HTLV-I Infections / blood
  • HTLV-I Infections / immunology*
  • Human T-lymphotropic virus 1
  • Humans
  • Independent Living
  • Japan
  • Male
  • Middle Aged

Substances

  • Anti-Citrullinated Protein Antibodies